|
PDCL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.3808000000034E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.70760000051918E-07 |
| Normal-vs-Stage2 |
2.470100E-02 |
| Normal-vs-Stage3 |
9.407800E-02 |
| Normal-vs-Stage4 |
1.505990E-02 |
| Stage1-vs-Stage2 |
1.615840E-01 |
| Stage1-vs-Stage3 |
6.583700E-02 |
| Stage1-vs-Stage4 |
8.005200E-01 |
| Stage2-vs-Stage3 |
8.178200E-01 |
| Stage2-vs-Stage4 |
4.542200E-01 |
| Stage3-vs-Stage4 |
4.249000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67547999999629E-05 |
| Normal-vs-AfricanAmerican |
3.442800E-03 |
| Normal-vs-Asian |
8.209500E-02 |
| Caucasian-vs-AfricanAmerican |
3.848000E-01 |
| Caucasian-vs-Asian |
7.728800E-01 |
| AfricanAmerican-vs-Asian |
9.821000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91980000002956E-06 |
| Normal-vs-Female |
3.518300E-02 |
| Male-vs-Female |
1.714160E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.855110E-03 |
| Normal-vs-Extreme_Weight |
4.14260000003441E-06 |
| Normal-vs-Obese |
1.097660E-02 |
| Normal-vs-Extreme_Obese |
2.042200E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.851600E-01 |
| Normal_Weight-vs-Obese |
3.765600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.182600E-01 |
| Extreme_Weight-vs-Obese |
3.463600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.666600E-01 |
| Obese-vs-Extreme_Obese |
1.152600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.626100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.620500E-03 |
| Normal-vs-Age(61-80Yrs) |
7.87119999956509E-07 |
| Normal-vs-Age(81-100Yrs) |
9.54920000000303E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.648400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.398370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.181600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.243700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.010300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.769600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.584000E-04 |
| Normal-VS-Type2 PRCC |
2.71539999996406E-06 |
| Normal-VS-KIRP CIMP |
3.589600E-01 |
| Normal-VS-Unclassified PRCC |
1.524150E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.450830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.197900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.295400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.281590E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.706640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.473500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.79859999999944E-05 |
| Normal-vs-N1 |
5.771000E-01 |
| Normal-vs-N2 |
3.488100E-02 |
| N0-vs-N1 |
1.254150E-02 |
| N0-vs-N2 |
8.537800E-01 |
| N1-vs-N2 |
2.505000E-01 |
|
|
